Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
OtherArticle

Identification of HMG-CoA reductase inhibitors as activators for human, mouse and rat constitutive androstane receptor (CAR)

Kaoru Kobayashi, Yosuke Yamanaka, Norihiko Iwazaki, Ikumi Nakajo, Masakiyo Hosokawa, Masahiko Negishi and Kan Chiba
Drug Metabolism and Disposition March 31, 2005, DOI: https://doi.org/10.1124/dmd.104.002741
Kaoru Kobayashi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yosuke Yamanaka
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Norihiko Iwazaki
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ikumi Nakajo
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Masakiyo Hosokawa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Masahiko Negishi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kan Chiba
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

DOI 
https://doi.org/10.1124/dmd.104.002741
PubMed 
15802384

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0090-9556
Online ISSN 
1521-009X

Article Versions

  • You are currently viewing an Earlier version of this article (March 31, 2005 - 08:05).
  • View the most recent version of this article

Author Information

Statistics from Altmetric.com

Article usage

Article usage: March 2005 to February 2021

AbstractFullPdf
Mar 2005803
Apr 2005350159
May 2005280183
Jun 2005566585
Jul 2005569678
Aug 2005205141
Sep 2005144929
Oct 2005306232
Nov 2005276428
Dec 2005114619
Jan 200692421
Feb 2006282721
Mar 200626109
Apr 2006212623
May 200681413
Jun 20061965
Jul 200663121
Aug 200693832
Sep 2006173130
Oct 2006255334
Nov 2006145919
Dec 2006143525
Jan 2007123125
Feb 2007112522
Mar 200753126
Apr 2007172016
May 200742513
Jun 200792526
Jul 200732213
Aug 2007101914
Sep 200762215
Oct 200792022
Nov 2007103027
Dec 200751513
Jan 200862925
Feb 200872615
Mar 200872313
Apr 2008131616
May 2008103120
Jun 2008142432
Jul 2008322620
Aug 200819167
Sep 2008251818
Oct 2008151913
Nov 2008162217
Dec 200851010
Jan 200975515
Feb 2009153426
Mar 20098138
Apr 2009679
May 200992115
Jun 20098136
Jul 2009111314
Aug 200982111
Sep 20099129
Oct 200917142
Nov 2009191410
Dec 200918109
Jan 2010121411
Feb 2010281221
Mar 2010171917
Apr 201015116
May 2010143211
Jun 20102587
Jul 2010211013
Aug 2010141713
Sep 201072110
Oct 2010112617
Nov 2010112114
Dec 20109129
Jan 2011102112
Feb 2011134018
Mar 2011191822
Apr 2011101618
May 201182424
Jun 2011142513
Jul 2011142724
Aug 201181816
Sep 2011102514
Oct 2011123722
Nov 201194431
Dec 2011131513
Jan 2012142015
Feb 201292724
Mar 2012142316
Apr 2012203031
May 2012132930
Jun 201271812
Jul 201273723
Aug 201291720
Sep 2012101119
Oct 2012172433
Nov 2012232624
Dec 2012171614
Jan 2013363521
Feb 2013182613
Mar 2013222317
Apr 2013121932
May 2013221910
Jun 2013111918
Jul 201372010
Aug 201341516
Sep 2013301712
Oct 2013161514
Nov 20134811
Dec 20138189
Jan 2014191211
Feb 20143187
Mar 20146179
Apr 2014172613
May 201411189
Jun 2014211910
Jul 201412239
Aug 20142106
Sep 201410157
Oct 2014101117
Nov 201412149
Dec 201410138
Jan 20153175
Feb 20155185
Mar 20158176
Apr 2015102110
May 20159148
Jun 20157228
Jul 2015161711
Aug 201571910
Sep 20156147
Oct 20156149
Nov 20154139
Dec 20156125
Jan 2016161717
Feb 201672016
Mar 2016231120
Apr 201681014
May 2016365
Jun 201681310
Jul 2016497
Aug 20166125
Sep 20163109
Oct 20165239
Nov 201642810
Dec 20162154
Jan 20171226
Feb 20170146
Mar 20173179
Apr 20172185
May 20170145
Jun 20170173
Jul 20173135
Aug 20171104
Sep 20173324
Oct 201731617
Nov 201723612
Dec 20171133
Jan 201812310
Feb 20180165
Mar 20180148
Apr 20180268
May 201811217
Jun 201802910
Jul 20180198
Aug 201801012
Sep 20180107
Oct 20180911
Nov 20180189
Dec 20184411
Jan 20191727
Feb 2019325
Mar 2019822
Apr 20191911
May 20191111
Jun 20191309
Jul 2019812
Aug 20192057
Sep 20191200
Oct 20191422
Nov 20191511
Dec 20193601
Jan 20201621
Feb 20201626
Mar 2020887
Apr 20201226
May 20201102
Jun 20202142
Jul 2020922
Aug 20201407
Sep 202020210
Oct 20201601
Nov 20202925
Dec 2020902
Jan 20211248
Feb 20212076

Next
Back to top

In this issue

Drug Metabolism and Disposition: 49 (3)
Drug Metabolism and Disposition
Vol. 49, Issue 3
1 Mar 2021
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Identification of HMG-CoA reductase inhibitors as activators for human, mouse and rat constitutive androstane receptor (CAR)
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
OtherArticle

Identification of HMG-CoA reductase inhibitors as activators for human, mouse and rat constitutive androstane receptor (CAR)

Kaoru Kobayashi, Yosuke Yamanaka, Norihiko Iwazaki, Ikumi Nakajo, Masakiyo Hosokawa, Masahiko Negishi and Kan Chiba
Drug Metabolism and Disposition March 31, 2005, DOI: https://doi.org/10.1124/dmd.104.002741

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
OtherArticle

Identification of HMG-CoA reductase inhibitors as activators for human, mouse and rat constitutive androstane receptor (CAR)

Kaoru Kobayashi, Yosuke Yamanaka, Norihiko Iwazaki, Ikumi Nakajo, Masakiyo Hosokawa, Masahiko Negishi and Kan Chiba
Drug Metabolism and Disposition March 31, 2005, DOI: https://doi.org/10.1124/dmd.104.002741
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • In Vivo Functional Effects of CYP2C9 M1L
  • Clearance pathways: fevipiprant with probenecid perpetrator
  • Predicting Volume of Distribution from In Vitro Parameters
Show more Article

Similar Articles

  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics